44 results on '"Gimenez, Gustavo"'
Search Results
2. Susceptibility of South American pear cultivars to brown spot of pear caused by Stemphylium vesicarium
3. Supplementary Figure Legend from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
4. Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
5. Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
6. Data from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
7. Supplementary Fig 3 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
8. Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
9. Supplementary Figure Legend from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
10. Supplementary Fig 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
11. Data from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
12. Supplementary Fig 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
13. Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
14. Supplementary Fig 3 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
15. Análisis energético en lecherías de la región Pampeana Argentina. Parte 2. Contabilidad energética
16. Análisis energético en lecherías de la región pampeana Argentina. Parte 1. Flujos de energía
17. Abstract CT108: Immunogenicity of Poly-ICLC matured dendritic cells as an adjuvant for NY-ESO-1 and Melan-A-MART-1 peptide vaccination compared to Montanide® ISA-51 VG, in study subjects with melanoma in complete clinical remission but at high risk of disease recurrence
18. Field Performance of Resistant Potato Genotypes Transformed with the EFR Receptor from Arabidopsis thaliana in the Absence of Bacterial Wilt (Ralstonia solanacearum)
19. Brown spot of pear, an emerging disease in Argentina: identification and pathogenicity characterization of Argentinean Stemphylium vesicarium isolates
20. IgE Epitope Mapping Using Peptide Microarray Immunoassay
21. Sustentabilidad asociada al traspaso generacional en un tambo
22. Author Correction: Novel Bead-Based Epitope Assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy
23. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
24. Novel Bead-Based Epitope Assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy
25. IgE and IgG4 binding to lentil epitopes in children with red and green lentil allergy
26. Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles
27. A new Luminex‐based peptide assay to identify reactivity to baked, fermented, and whole milk
28. Partially hydrolyzed whey formula intolerance in cow's milk allergic patients
29. Tolerance of Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
30. Sensitization phenotypes based on protein groups and associations to allergic diseases in children
31. A New Luminex-Based Peptide Assay to Identify Different Degrees of Milk Allergic Reactivity
32. Comparison of IgE Epitope Mapping By Peptide Microarray and a Novel Luminex-Based Peptide Assay
33. Profile of a milk-allergic patient who tolerated partially hydrolyzed whey formula
34. Relationship of IgE to basophil phenotypes in peanut-sensitized adults
35. The Use Of The ISAC Mircroarray Platform In Food Allergic Patients
36. Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy
37. The Use of the ISAC Microarray Platform in Food Allergic Patients
38. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens
39. A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay
40. Evaluation of flu vaccines with regard to their egg protein content
41. Reply
42. Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow’s milk allergy
43. Dietary antigens, epitope recognition, and immune complex formation in recent onset psychosis and long-term schizophrenia
44. Components of Resistance to Colletotrichum acutatum in Strawberry (Fragaria ×ananassa Duch.)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.